Showing results (951-960 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|May 14, 2004
Pharmacokinetic optimisation of treatment with oral etoposideGiuseppe Toffoli, Giuseppe Corona, Barbara Basso, et al.Clinical Pharmacokinetics|May 14, 2004
Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjectsRuediger Nave, Thomas D Bethke, Sjoerd P van Marle, et al.Clinical Pharmacokinetics|April 17, 2004
Treatment of anxiety and depression in transplant patients: pharmacokinetic considerationsCatherine C Crone, Geoffrey M GabrielClinical Pharmacokinetics|April 17, 2004
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosagesFederico Pea, Pierluigi Viale, Anna Candoni, et al.Clinical Pharmacokinetics|December 17, 2003
Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activityDimiter Terziivanov, Kristina Bozhinova, Velislava Dimitrova, et al.Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.Clinical Pharmacokinetics|January 30, 2004
Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapySerge van Ruth, Ron A A Mathôt, Rolf W Sparidans, et al.Clinical Pharmacokinetics|October 29, 2004
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infectionsPamela A Moise-Broder, Alan Forrest, Mary C Birmingham, et al.Clinical Pharmacokinetics|February 1, 1992
Clinical pharmacokinetics of neuromuscular blocking drugsS Agoston, R H Vandenbrom, J M WierdaPageof 348